RGEN News and Press, Repligen Corporation From 08/01/19

Reports record quarterly revenue of $70.7 million, representing 48% year-over-year growth and 46% organic growth Raises revenue guidance to $264-$268 million for full year 2019, representing 29%-31% organic growth Completes acquisition of process analytics innovator C Technologies ...

WALTHAM, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2019 financial results on Thursday, August 1, 2019. The Company will issue a press release before the market opens and will host a conference ...

Bridgebio Pharma (NASDAQ: BBIO ) initiated with Buy rating and $42 (53% upside) price target at Goldman Sachs. Initiated with Buy rating and $38 price target at Jefferies. Initiated with Outperform rating and $49 price target at BMO. Initiated with Outperform rating and $34 price target at S...

WALTHAM, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced the closing of its previously announced concurrent underwritten public offerings of an aggregate of 1,587,000 shares of its common stock (the “Sharesȁ...

Repligen (NASDAQ: RGEN ) has priced its public offerings of 1,380,000 common shares of at $87.00 per share, for gross proceeds of ~$120M, and $250M 0.375% Convertible Senior Notes due 2024. More news on: Repligen Corporation, Healthcare stocks news, Read more ...

WALTHAM, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced the pricing of concurrent underwritten public offerings of 1,380,000 shares of its common stock (the “Shares”) at a public offering price of $87.00 ...

Gainers: JBHT   +6.1% . HCR   +2.9% . ARD   +2.7% . HX   +2.6% . TEO   +1.8% . More news on: J.B. Hunt Transport Services, Inc., Hi-Crush Inc., Ardagh Group S.A., Stocks on the move, Read more ...

Repligen (NASDAQ: RGEN ) slips  3%  after hours in reaction to its $100M public offering of common stock and $250M public offering of convertible senior notes due 2024. More news on: Repligen Corporation, Healthcare stocks news, Stocks on the move, Read more ...

WALTHAM, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced that it has commenced concurrent underwritten public offerings of $100,000,000 in shares of its common stock (the “Shares”) and $250,000,000 aggrega...

Investing in companies with superior growth can lead to outstanding returns over the long term. However, picking the best growth stocks is easier said than done, and a good idea without solid implementation can do more harm than good. This is especially true among growth stocks, since these ...